P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
 

 

 

 

 

 

 

-->

Recent Headlines

Thursday, Aug 28

FDA Removes Clinical Hold on Early Trials of Cancer Drug Vantictumab

Engineered Cartilage Regenerates Joints

Irinotecan-Based Therapy Shows Promise in Subset of Stage III Colon Cancer Patients

Regulatory Approval Sought for LDL Cholesterol-Lowering Drug Evolocumab

New Bedside Scanning Device Ensures Patients Get Correct Pills

Wednesday, Aug 27

Scientists Say New Antibacterial Approach Could Resolve Serious Skin Infections

Survey: Ellipta Most Likely to Replace Spiriva for Treatment of COPD

Promacta (Eltrombopag) Gets Additional Indication

Teva Recalls ‘Super Potent’ Parkinson’s Disease Medication

FDA Grants ‘Priority Review’ Designation for Ivabradine for Treatment of Chronic Heart Failure

Tuesday, Aug 26

New Diabetes Drug Jardiance (Empagliflozin) Now Available in U.S.

FDA Recommends Not Using Lidocaine to Treat Teething Pain

Report: Vitamin D Does Not Stop Heart Attack or Stroke

Crizotinib/Pembrolizumab Combo to Be Tested in Lung Cancer Patients

New Guidelines for Overweight Adults With Heart Risks

Monday, Aug 25

FDA Approves Triumeq (Abacavir/Dolutegravir/Lamivudine) as Single-Pill Regimen for HIV-1 Infection

Report: Medicaid Reimbursements May Affect Cancer Screening Rates Among Beneficiaries

Regulatory Approval Sought for Long-Acting Schizophrenia Treatment Aripiprazole Lauroxil

American Heart Association Issues E-Cigarette Recommendations

Cancer Immunotherapy Pembrolizumab Expected to Be Approved Soon

Friday, Aug 22

Positive Phase III Results Reported for BAX 855 in Treatment of Hemophilia A

New Skin Wound-Healing Compound Shows Promise in First Clinical Trial

Psoriasis Drug Ixekizumab Superior to Etanercept in Phase III Studies

Hydrocodone Combination Products Move to Schedule II

FDA Expands Eliquis Label to Include Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Thursday, Aug 21

Report: Payers Exert Cost Controls on High-Cost Biologics to Treat Autoimmune Diseases

FDA Approves First ZnT8Ab Autoantibody Test to Help Diagnose Type-1 Diabetes

Could Health Systems Pull Out of Non-Expansion States?

Study Questions Use of Acute Hemodialysis Treatment

Asthma Drug Arnuity Ellipta (Fluticasone Furoate) Wins FDA Nod

Wednesday, Aug 20

Study: Antibacterial Soap Exposes Health Workers to High Triclosan Levels

Ceftazidime/Avibactam Shows Promise in Patients With Complicated Intra-Abdominal Infections

FDA Approves Cerdelga (Eliglustat) for Gaucher Disease

Scientists Claim ‘Superbug’ Breakthrough

Common Antibiotic Linked to Heart Deaths

Tuesday, Aug 19

FDA Approval Sought for Thyroid Cancer Drug Lenvatinib

Survey: U.S. Rheumatologists Embrace Xeljanz (Tofacitinib) After Label Change

Quasi-Legal Drug Fifteen Times Stronger Than Heroin Hides in Plain Sight

FDA Grants Tentative Approval for Basaglar (Insulin Glargine Injection)

Chinese Cyberattack Steals 4.5 Million Patients’ Data From Hospital Records

Monday, Aug 18

FDA Advisors Back Tiotropium Respimat for Maintenance Treatment of COPD

FDA Approves Plegridy (Peginterferon Beta-1a) for Treatment of Multiple Sclerosis

New X-Ray Imaging Method for Cystic Fibrosis

Intra-Articular Treatment (Ampion) Shows Promise in Early OA Trial

Study: Invasion of Americas by Mosquito-Borne Virus Likely

Friday, Aug 15

NSAIDs Benefit Overweight Breast Cancer Patients

Wide Variation in Hospital Charges for Blood Tests Called ‘Irrational’

FDA Questions Abuse-Deterrent Hydrocodone/Acetaminophen Combo Tablet

Ribavirin-Free Regimen (ACH-3102/Sofosbuvir) Achieves 100% Response Rate in HCV Patients

Avastin (Bevacizumab) Plus Chemotherapy Gets FDA Nod for Treatment of Advanced Cervical Cancer

Thursday, Aug 14

Tests Diagnose Invasive Aspergillosis With 100% Accuracy

First Biosimilar Monoclonal Antibody (Remsima) Submitted for FDA Review

Report: Bacteria Growing Less Susceptible to Common Hospital Antiseptic

FDA Approves New Type of Sleep Drug, Belsomra (Suvorexant)

CDC Advisors Recommend Prevnar 13 Vaccine for Older Adults

Wednesday, Aug 13

FDA Approves Donor-Lung Preservation Device

Model Predicts COPD Hospital Readmission

Survey Finds Continued Uptake of Novel Antidepressants and Antipsychotics in Unipolar Depression Market

Study: Two in Five Americans at Risk of Type-2 Diabetes

Positive Phase III Results Reported for Gout Drug Lesinurad

Tuesday, Aug 12

Survey: Imatinib and Sunitinib Will Continue to Dominate GIST Therapy Through 2023

Study: Blacks, Women Face Greater Burden From CVD Risk Factors

FDA Approves First Non-Invasive DNA Screening Test for Colorectal Cancer

Parkinson’s Foundation Spotlights Latest Research

WHO Backs Use of Experimental Ebola Drugs as Death Toll Tops 1,000

Monday, Aug 11

New Treatment Guidelines for Irritable Bowel Syndrome

FDA Updates Velcade (Bortezomib) Labeling to Include Retreatment in Patients with Multiple Myeloma

FDA Approves Invokamet (Canagliflozin/Metformin) for Diabetes Patients

Positive Results Reported for Concentrated Insulin (BIOD-531) in Mid-Stage Trial

Study: One in Six Lupus Patients Readmitted to Hospital Within 30 Days of Discharge